Articles tagged with Pharmac
New Cancer Infusion Centre Opens in Henderson for West Auckland Patients
7 hours ago | 29 viewsA new community-based cancer infusion centre is opening in Henderson, West Auckland, allowing patients to receive treatment closer to home and reducing travel to Auckland City Hospital. This service, operating five days a week with four treatment chairs, complements a recent infusion centre at Waitākere Hospital and is part of a nationwide effort to expand community cancer care. Supported by a $210 million investment from Budget 2024 and increased Pharmac funding, New Zealand plans to open 14 new infusion centres and expand 14 others to meet growing demand and improve patient access.
Tags: West Auckland cancer treatment infusion service Henderson Simeon Brown Health New Zealand Te Whānau o Waipareira Waitākere Hospital Pharmac Budget 2024Health Minister Welcomes New Agreement for Senior Medical Officers in NZ
3 days ago | 71 viewsHealth Minister Simeon Brown has welcomed the ratification of a new collective agreement for approximately 5,500 senior doctors represented by the Association of Salaried Medical Specialists (ASMS). He emphasized the critical role senior doctors play in the healthcare system and their contribution to achieving government health targets. The agreement follows similar approvals for other health sector groups and reflects constructive engagement between ASMS and Health New Zealand to ensure continued patient care.
Tags: Simeon Brown Association of Salaried Medical Specialists ASMS Senior Medical Officers Health Minister APEX pharmacy PSA Allied Public Health STONZ Resident Medical Officers Health New Zealand collective agreementEasier, Affordable Kids’ Health Treatment via Community Pharmacies in NZ from June
3 weeks ago | 269 viewsFrom June, New Zealand will expand funded treatment services through community pharmacies to provide easier and more affordable care for children’s common health conditions, reducing reliance on GP appointments. Pharmacists will be authorized to assess patients and supply subsidized medicines for issues like pain, fever, scabies, and urinary tract infections, supported by a $5 million annual fund to ensure nationwide availability. This initiative aims to improve timely access to healthcare, especially in rural and underserved areas, by leveraging pharmacists as accessible and trusted health professionals.
Tags: Simeon Brown David Seymour Health New Zealand Pharmacists community pharmacies GP appointments Extended Pharmacy Services Fund Pharmaceutical Schedule New Zealand health children's healthcareNZ Expands Cancer Infusion Services Nationwide for Faster, Local Treatment
3 weeks ago | 232 viewsNew Zealand is expanding community infusion services with 14 new centres and 14 expansions to provide thousands more cancer treatments closer to patients’ homes, supported by a $210 million investment from Budget 2024. This initiative responds to a 12% increase in demand, adding 218 more chair-days weekly and addressing the need for increased capacity following the introduction of 33 new cancer medicines funded by Pharmac. The government aims to improve cancer outcomes by ensuring timely, accessible treatment nationwide, while recruiting additional healthcare staff to support the expanded services through 2028.
Tags: Simeon Brown Pharmac Budget 2024 New Zealand cancer treatment infusion centres community infusion services healthcare expansion cancer care medical workforcePharmac Funds New Combination Therapies for Chronic Lymphocytic Leukaemia in NZ
1 month ago | 291 viewsAssociate Health Minister David Seymour applauds Pharmac’s decision to fund two new combination therapies—venetoclax with ibrutinib or obinutuzumab—as first-line treatments for chronic lymphocytic leukaemia (CLL), along with expanded access to ibrutinib as a second-line option. These treatments, available from May 2026, aim to improve patient outcomes by enabling longer remission, reducing the need for chemotherapy and hospital visits, and accommodating patient feedback gathered through community consultation. Since the government increased Pharmac’s budget, over 200,000 patients have benefited from funding decisions on 133 medicines, including 46 cancer treatments, reflecting a more collaborative approach with the patient community.
Tags: David Seymour Pharmac chronic lymphocytic leukaemia CLL venetoclax ibrutinib obinutuzumab cancer medication New Zealand cancer patientsNew Public Finance Amendment Act Enhances Fiscal Transparency in NZ
1 month ago | 314 viewsNew legislation requires the Treasury to include specific fiscal risk statements in economic and fiscal updates, addressing previously unclear risks such as time-limited funding for Pharmac medicines. The Act removes the requirement for Treasury to report on wellbeing, focusing instead on core economic and fiscal advice, and advances the delivery date of the Pre-Election Economic and Fiscal Update by five working days to better inform voters. This law will take effect on July 1, 2026.
Tags: Nicola Willis Public Finance Amendment Act Treasury Pharmac PREFU New Zealand Finance Minister Parliament fiscal risksNew Public Finance Amendment Act Enhances Fiscal Transparency in NZ
1 month ago | 249 viewsNew legislation requires the Treasury's economic and fiscal updates to include specific statements on fiscal risks, addressing previous omissions like time-limited funding for essential medicines. It also removes the Treasury's obligation to report on "wellbeing," refocusing its role on core economic and fiscal advice, and advances the delivery date of the Pre-Election Economic and Fiscal Update to give voters more time to consider election choices. The Act is set to take effect by July 1, 2026.
Tags: Nicola Willis Public Finance Amendment Act Treasury Pharmac New Zealand PREFU Finance Minister Parliament fiscal risks economic outlookPharmac Expands Funding for Trikafta, Alyftrek & Kalydeco for All Children with Cystic Fibrosis
1 month ago | 355 viewsAssociate Health Minister David Seymour welcomes Pharmac’s decision to fund Trikafta and Alyftrek for all children with cystic fibrosis regardless of age from April 1, 2026, expanding access beyond the previous age limits. Pharmac will also widen access to Kalydeco for all eligible patients and allow doctors to prescribe these lifechanging treatments based on clinical judgment, addressing the urgent needs of young children affected by cystic fibrosis. This decision follows positive public consultation and reflects Pharmac’s commitment to working with the cystic fibrosis community to improve health outcomes and reduce pressure on the health system.
Tags: David Seymour Pharmac Trikafta Alyftrek Kalydeco cystic fibrosis children health minister New Zealand funding decisionPharmac's Deal with Medtronic to Save $1.2M Annually on Drug-Eluting Stents
1 month ago | 350 viewsPharmac has proposed a provisional agreement with Medtronic New Zealand to supply 65% of drug-eluting stents to public hospitals, potentially saving $1.2 million annually while ensuring access to high-quality stents. The proposal, developed with input from the Interventional Cardiology Advisory Group, aims to improve procurement efficiency and collaboration between Pharmac and Health New Zealand. Public consultation is open until April 28 to gather feedback from healthcare professionals and stakeholders before finalizing the deal for implementation starting June 2026.
Tags: David Seymour Pharmac Medtronic New Zealand Health New Zealand Interventional Cardiology Advisory Group Associate Health Minister public hospitals Principal Supply Status Pharmaceutical ScheduleGovernment to Shift Ambulance Medicine Funding to Pharmac for Better Care and Savings
1 month ago | 422 viewsThe Government plans to transfer funding responsibility for ambulance medicines from Health New Zealand and ACC to Pharmac to improve procurement efficiency, ensure nationwide access to consistent emergency medicines, and save costs. This change will create a single nationally consistent medicine list for ambulance services, enhancing continuity of care between ambulance providers and hospitals while leveraging Pharmac’s expertise and buying power. Public consultation on the proposal is open from March 12 to April 2, 2024, with implementation targeted for July 1, 2026.
Tags: David Seymour Simeon Brown Pharmac Health New Zealand ACC ambulance medicines emergency care medicine procurement New Zealand government pharmaceutical scheduleAnna Adams Appointed New Solicitor-General and Chief Executive of Crown Law Office
2 months ago | 383 viewsAnna Adams has been appointed Solicitor-General and Chief Executive of the Crown Law Office, bringing 28 years of extensive public law experience and strong private-sector leadership. She has acted as lead counsel in over 100 significant cases and held senior roles at Meredith Connell and PHARMAC. Her appointment, effective from 11 May 2026 for five years, is praised for her judgment, integrity, and ability to provide strong leadership in this key constitutional role.
Tags: Anna Adams Judith Collins Crown Law Office Bankside Chambers Meredith Connell PHARMAC Yale Law SchoolNew Zealand Proposes Funding Letermovir to Prevent Infection After Stem Cell Transplants
2 months ago | 368 viewsAssociate Health Minister David Seymour and Health Minister Simeon Brown support Pharmac’s proposal to fund letermovir from May 2026 to prevent serious CMV infections in stem cell transplant patients and those with severe immunosuppression. This initiative aims to improve patient outcomes by reducing complications, hospital stays, and healthcare system pressure, aligning with the Government’s commitment to expanding stem cell transplant capacity and enhancing cancer treatment access. Pharmac is currently seeking public feedback on the proposal, inviting input from affected patients, families, health professionals, and advocacy groups.
Tags: David Seymour Simeon Brown Pharmac letermovir stem cell transplant New Zealand CMV infection cancer treatment healthcare system Faster Cancer TreatmentNew Collective Agreements Boost Salaries and Support for NZ Public Health Nurses
2 months ago | 393 viewsHealth Minister Simeon Brown has welcomed the ratification of new collective agreements for approximately 3,500 Public Health and Mental Health Nurses in New Zealand, which include salary increases, lump sum payments, and enhanced professional development allowances. The agreements also commit to recruiting over 550 additional nursing positions to strengthen frontline services. This follows recent approvals of agreements for other health sector workers, highlighting collaborative efforts to ensure staff support and quality care for New Zealanders.
Tags: Simeon Brown Health Minister Public Service Association Public Health Nurses Mental Health Nurses Health New Zealand Nurse Practitioners APEX pharmacy APEX psychologists APEX dietitiansHealth Minister Welcomes New Pay Deal for 12,300 Health NZ Workers
2 months ago | 375 viewsHealth Minister Simeon Brown has welcomed the ratification of a new collective agreement for approximately 12,300 Allied, Public Health, Scientific, and Technical workers represented by the Public Service Association. The agreement includes a 2.5% pay increase in the first year, a 2% increase in the second year, a $500 lump sum payment, a new pay scale for Sterile Sciences Technicians, and a $400,000 professional development fund. This settlement follows recent approvals for other health sector agreements, highlighting ongoing progress in workforce negotiations.
Tags: Simeon Brown Health Minister Allied Health Public Health Scientific Technicians Public Service Association Health New Zealand APEX Pharmacy APEX Psychologists Sterile Sciences TechniciansPharmac Proposes Widened Access to Immunotherapy for Advanced Melanoma Patients
2 months ago | 395 viewsAssociate Health Minister David Seymour and Health Minister Simeon Brown support Pharmac’s proposal to expand access to immunotherapy medicines nivolumab and ipilimumab for people with stage 3B to stage 4 melanoma starting May 2026, aiming to improve treatment outcomes and reduce cancer recurrence. These medicines, used together before surgery, can enhance immune response, potentially reduce the need for further treatment, and save health resources by decreasing infusion hours and hospital visits. The government emphasizes faster access to effective cancer care, backed by significant investment in new medicines, while Pharmac seeks public and clinical feedback on the proposal before finalizing the decision.
Tags: David Seymour Simeon Brown Pharmac nivolumab ipilimumab melanoma New Zealand cancer treatment immunotherapy Melanoma New Zealand